BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
|Articles|August 24, 2019
- August 2019 Back to School
- Volume 85
- Issue 8
The Role of the Pharmacist With Cholesterol Management: Focusing on New Guidelines and PCSK9 Inhibitors
Continuing education for managing cholesterol with PCSK9 inhibitors.
Advertisement
Faculty
Joseph J. Saseen, PharmD, BCPS, BCACP, CLS, Professor and Vice Chair, Department of Clinical Pharmacy; Professor, Department of Family Medicine; University of Colorado Anschutz Medical Campus, Aurora Colorado
Educational Objectives
At the completion of this activity, the participant will be able to:
- Examine the pathophysiology, complications, and burden associated with hypercholesterolemia
- Identify updates to guidelines and the appropriate role of PCSK9 inhibitors in the management of hypercholesterolemia
- Explore various ways that pharmacists can make an impact and provide education for patients with hypercholesteremia to optimize outcomes
Target Audience: Pharmacists
Activity Type: Application
Release Date: August 12, 2019
Expiration Date: August 12, 2020
Estimated Time to Complete Activity: 2.0 hours
Fee: This lesson is offered for free at
Articles in this issue
about 7 years ago
A Hospital and Physician Share Liability for Prescribing Opioidsabout 7 years ago
Motivational Interviewing Offers a Path to Improved Adherenceabout 7 years ago
Drug Shortages Raise Critical Safety Concernsabout 7 years ago
Case Study: Albuterolabout 7 years ago
340B Specialists Help Maintain Program Integrityabout 7 years ago
How Can Patients Prevent and Treat Fall Allergies?about 7 years ago
Case Study: Vitamins for Eye Healthabout 7 years ago
Pet Peeves (August 2019)Advertisement
Related to this article
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
A Novo Nordisk–funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, although the findings cannot show causation.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
2
Statin Myths: Why Patients Avoid Cholesterol-Lowering Therapy
3
Tirzepatide Linked to More Weight Loss Than Semaglutide 7.2 mg
4
Pharmacist, Advocate, Ally: Delivering Comprehensive Gender-Affirming Care
5